The abstract is read at the publisher; the summary is JClub's.
Microbial-protein panels from pediatric inflammatory bowel disease samples diagnose IBD more accurately than human-only or combined panels, with the ascending colon providing the best sampling site.
- Why it matters: Pediatric IBD has complex subtype distinctions, and conventional biomarkers lack enough power to separate Crohn’s disease from ulcerative colitis.
- What they did: The study profiled mucosal luminal interface samples across the terminal ileum, ascending colon, and descending colon, analyzing human proteomes and microbial metaproteomes with protein-set selection, feature selection, and machine learning.
- The result: Microbial-only panels achieved highly accurate diagnostic performance, and ascending-colon signals aligned with richer microbial diversity, supporting microbial dysbiosis–linked pathways and candidate subtype-stratifying biomarkers.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.